Recent news on Norelgestromin Ethinyl Estradiol

UPDATE: Data Show Low Incidence Of Breakthrough Bleeding With ...  -  May 9, 2007
PR Newswire (press release),...(norelgestromin/ethinyl estradiol transdermal system), ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl estradiol), DITROPAN XL(R) (oxybutynin chloride),

Report Shows Popular Birth Control Pill, ORTHO TRI-CYCLEN(R) LO ...  -  Apr 12, 2007
Drug Newswire (press release),...is committed to meeting the needs of providers and patients with products such as ORTHO EVRA(R) (norelgestromin/ethinyl estradiol transdermal system),

Results of Two Epidemiological Studies Provide Important New ...  -  Apr 12, 2007
Drug Newswire (press release),16 /PRNewswire/ -- Ortho Women's Health & Urology, the maker of the ORTHO EVRA(R) (norelgestromin/ethinyl estradiol transdermal system) birth control patch,

Contraceptive Patch More Likely Than Pill to Cause Venous ...  -  Feb 20, 2007
Medscape (subscription)The study involved 49048 women who used the norelgestromin/ethinyl estradiol patch (Ortho Evra) and 202344 who used norgestimate-containing oral

FDA Safety Changes: Ortho Evra, Avastin, Trizivir  -  Dec 13, 2006
Medscape (subscription)On September 20, the FDA approved safety labeling revisions for a norelgestromin/ethinyl estradiol transdermal system (Ortho Evra, made by Ortho-McNeil

Nurse Practitioners Of Women's Health Publishes Issue Highlighting ...  -  Dec 11, 2006
Medical News Today (press release),Inc., and makers of ORTHO TRI-CYCLEN® Lo (ethinyl estradiol/norgestimate) and ORTHO EVRA® (norelgestromin/ethinyl estradiol transdermal system),

Nurse Practitioners of Women's Health Publishes Issue Highlighting ...  -  Dec 6, 2006
Drug Newswire (press release),Inc. and makers of Ortho Tri-Cyclen(R) Lo (norgestimate/ethinyl estradiol) and Ortho Evra(R) (norelgestromin/ethinyl estradiol transdermal system),

FDA- MedWatch - Ortho Evra (norelgestromin/ethinyl estradiol)  Sep 20, 2006
ROCKVILLE, Md., Sept. 20, 2006-Ortho-McNeil and FDA notified healthcare professionals and patients about revisions to the prescribing ... -PharmaLive.com

Ortho Evra Patch Linked to Risk for Venous Thromboembolism  Sep 21, 2006
...company) have notified healthcare professionals regarding changes to the safety labeling for a weekly norelgestromin/ethinyl estradiol transdermal system ... -Medscape (subscription)

FDA Warns of Serious Blood Clot Risk in Women on Ortho Evra ...  Sep 21, 2006
...epidemiology studies that evaluated the risk of developing a serious blood clot in women using Ortho Evra (norelgestromin/ethinyl estradiol) compared to women ... -DG News

Health Canada Reviews Birth Control Patch Risks  Sep 21, 2006
The Ortho-Evra EVRA (norelgestromin/ethinyl estradiol transdermal system) patch may carry an increased risk of blood clots, according to a study. ... -Toronto Daily News

Nurse Practitioners Of Women's Health Publishes Issue Highlighting ...  -  Dec 11, 2006
Medical News Today (press release),Inc., and makers of ORTHO TRI-CYCLEN® Lo (ethinyl estradiol/norgestimate) and ORTHO EVRA® (norelgestromin/ethinyl estradiol transdermal system),

Nurse Practitioners of Women's Health Publishes Issue Highlighting ...  -  Dec 6, 2006
Drug Newswire (press release),Inc. and makers of Ortho Tri-Cyclen(R) Lo (norgestimate/ethinyl estradiol) and Ortho Evra(R) (norelgestromin/ethinyl estradiol transdermal system),

Survey Sheds Light On Mistaken Identities Of Interstitial Cystitis ...  Aug 20, 2006
...live healthier lives and to meeting the needs of providers and patients with products such as ORTHO EVRA® (norelgestromin/ethinyl estradiol transdermal system ... -Medical News Today

Ortho Celebrates 75 Years of Partnering With Women  Jul 25, 2006
...a new delivery system to appeal to women seeking more convenience in their contraceptive choice - ORTHO EVRA(R) (norelgestromin/ethinyl estradiol), the first ... -PR Newswire



Report Shows Popular Birth Control Pill, Ortho Tri-Cyclen(R) LO ...  May 11, 2006
...is committed to meeting the needs of providers and patients with products such as ORTHO EVRA(R) (norelgestromin/ethinyl estradiol transdermal system), ORTHO TRI ... - Medical News Today



Evidence on Ortho Evra Patch Thrombosis Risk Is Contradictory  Feb 17, 2006
Interim results of an epidemiologic study indicated that women who use Ortho Evra (norelgestromin/ethinyl estradiol transdermal system) had about a two-fold ... - MedPage Today,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional